Grants and Contributions:
Title:
Development of export relationship in China for Molecular Pathology antibodies
Agreement Number:
915829
Agreement Value:
$25,750.00
Agreement Date:
Oct 26, 2018 - Mar 31, 2019
Description:
GenomeMe is a manufacturer specializing in molecular pathology antibodies for diagnostics. With the availability and competitiveness of quality and price, we aim to expand our business and market in East China’s healthcare market.
Organization:
National Research Council Canada
Expected Results:
CanExportCanExport is designed to provide direct financial assistance to small- and medium-sized enterprises seeking to develop new export market opportunities and markets, especially in high-growth emerging markets.
Location:
Richmond, British Columbia, CA V6V 2J6
Reference Number:
172-2018-2019-Q3-915829
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
801765397
Recipient Type:
For-profit organization
Recipient's Legal Name:
GenomeMe Lab Inc.
Federal Riding Name:
Steveston--Richmond East
Federal Riding Number:
59031
Program:
CanExport
Program Purpose:
CanExportCanExport is designed to provide direct financial assistance to small- and medium-sized enterprises seeking to develop new export market opportunities and markets, especially in high-growth emerging markets.
Coverage:
CanExport - CanExport projects lead to increased export diversification and growth for Canadian small and medium enterprises.
NAICS Code:
325413